Status: Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Participants needed: 405
Trial details
Phase: Phase 2Age: 18-74Biological sex: AllType: InterventionalSponsor: Inmagene LLCUpdated: May 27, 2026Locations: 23
Eligibility criteria
Moderate-to-severe AD [+7]
Positive hepatitis B, hepatitis C, or human immunodeficiency virus infection [+6]